ATE154646T1 - Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide - Google Patents

Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide

Info

Publication number
ATE154646T1
ATE154646T1 AT91916041T AT91916041T ATE154646T1 AT E154646 T1 ATE154646 T1 AT E154646T1 AT 91916041 T AT91916041 T AT 91916041T AT 91916041 T AT91916041 T AT 91916041T AT E154646 T1 ATE154646 T1 AT E154646T1
Authority
AT
Austria
Prior art keywords
hepatitis
examination
polynucleotides
hcv
reagents
Prior art date
Application number
AT91916041T
Other languages
English (en)
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Amy J Weiner
Jang Han
Michael Steven Urdea
Bruce Duncan Irvine
Janice A Kolberg
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE154646T1 publication Critical patent/ATE154646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91916041T 1990-08-10 1991-08-12 Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide ATE154646T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56620990A 1990-08-10 1990-08-10

Publications (1)

Publication Number Publication Date
ATE154646T1 true ATE154646T1 (de) 1997-07-15

Family

ID=24261960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916041T ATE154646T1 (de) 1990-08-10 1991-08-12 Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide

Country Status (19)

Country Link
EP (1) EP0543924B1 (de)
JP (1) JP2714255B2 (de)
KR (1) KR0163964B1 (de)
AT (1) ATE154646T1 (de)
AU (1) AU660940B2 (de)
BG (1) BG61615B1 (de)
CA (1) CA2089080C (de)
CZ (1) CZ282573B6 (de)
DE (1) DE69126617T2 (de)
DK (1) DK0543924T3 (de)
ES (1) ES2104720T4 (de)
FI (1) FI106214B (de)
GR (1) GR3024480T3 (de)
HU (2) HU227499B1 (de)
NO (1) NO308621B1 (de)
PL (1) PL169035B1 (de)
RO (1) RO109952B1 (de)
RU (1) RU2180354C2 (de)
WO (1) WO1992002642A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1459792A (en) * 1991-01-14 1992-08-27 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
KR0185426B1 (ko) * 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
DE69223562T2 (de) * 1991-08-27 1998-06-04 Hoffmann La Roche Verfahren und Reagenzien zum Nachweis von Hepatitis C
EP0532258A2 (de) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonukleotide und Verfahren zum Nachweis von HCV-Gentypen
ES2065863T3 (es) 1991-11-21 2003-09-01 Common Services Agency Analisis para la deteccion de virus de la hepatitis c.
AU4387193A (en) * 1992-05-29 1993-12-30 Abbott Laboratories Ligase chain reaction starting with rna sequences
JPH0670800A (ja) * 1992-08-26 1994-03-15 Imuno Japan:Kk Ｈｃｖゲノムの多様性検出方法、プライマー
CA2143678A1 (en) * 1992-09-10 1994-03-17 Kevin P. Anderson Compositions and methods for treatment of hepatitis c virus-associated diseases
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
ES2133529T3 (es) 1992-11-27 1999-09-16 Innogenetics Nv Procedimiento para tipificar aislamientos de hcv.
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
AU2001292151B2 (en) 2000-08-17 2006-05-04 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20030180814A1 (en) * 2002-03-21 2003-09-25 Alastair Hodges Direct immunosensor assay
DE60330877D1 (de) * 2002-07-26 2010-02-25 Abbott Lab Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado
JP2696116B2 (ja) * 1988-09-30 1998-01-14 財団法人阪大微生物病研究会 非ａ非ｂ肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするｄｎａ
CA2046919A1 (en) * 1989-02-14 1990-08-15 Mark P. Pasek Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
JP2656996B2 (ja) * 1989-05-18 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
SU1742331A1 (ru) * 1989-08-10 1992-06-23 Институт Органического Синтеза Ан Латвсср Рекомбинантна плазмидна ДНК @ BLV 51-3, кодирующа кор-антиген вируса гепатита В с экспонированным на его поверхности эпитопом BLV @ 51 (56-103), вируса лейкоза крупного рогатого скота способ ее конструировани и штамм бактерий ЕSснеRIснIа coLI - продуцент кор-антигена вируса гепатита В с экспонированным на его поверхности эпитопом BLV @ 51 (56-103)
EP0461863A1 (de) * 1990-06-12 1991-12-18 Immuno Japan Inc. Oligonukleotid-Primer und ihre Anwendung zum Nachweis von non-A, non-B-Hepatitisvirus mit grosser Genauigkeit
EP0464287A1 (de) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, Non-B Hepatitis Virus genomisches DNS und Antigenpolypeptide
EP0469348B1 (de) * 1990-07-11 1997-03-12 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. cDNS-Sequenz und Detektion des Hepatitis C-Virus

Also Published As

Publication number Publication date
FI930582A0 (fi) 1993-02-10
PL169035B1 (pl) 1996-05-31
BG61615B1 (bg) 1998-01-30
NO930429D0 (no) 1993-02-08
BG97435A (bg) 1994-03-24
CA2089080A1 (en) 1992-02-11
NO930429L (no) 1993-04-05
WO1992002642A1 (en) 1992-02-20
CZ16793A3 (en) 1993-05-12
DK0543924T3 (da) 1997-09-08
CZ282573B6 (cs) 1997-08-13
EP0543924A4 (en) 1993-07-21
ES2104720T4 (es) 1997-12-16
FI106214B (fi) 2000-12-15
EP0543924B1 (de) 1997-06-18
EP0543924A1 (de) 1993-06-02
KR0163964B1 (ko) 1998-11-16
ES2104720T3 (es) 1997-10-16
JPH06503707A (ja) 1994-04-28
HUT69140A (en) 1995-08-28
RO109952B1 (ro) 1995-07-28
HU227499B1 (en) 2011-07-28
DE69126617D1 (de) 1997-07-24
GR3024480T3 (en) 1997-11-28
NO308621B1 (no) 2000-10-02
JP2714255B2 (ja) 1998-02-16
FI930582L (fi) 1993-04-07
AU8509991A (en) 1992-03-02
RU2180354C2 (ru) 2002-03-10
CA2089080C (en) 2007-04-03
AU660940B2 (en) 1995-07-13
HU9300323D0 (en) 1993-05-28
DE69126617T2 (de) 1997-10-02

Similar Documents

Publication Publication Date Title
DE69126617D1 (de) Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide
ATE211772T1 (de) Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
RU93004904A (ru) Способ обнаружения вируса гепатита с, набор, способ получения крови, реагент
BR9509421A (pt) Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos
ES2114850T3 (es) Deteccion de los virus htlvi y htlvii mediante hibridacion.
DE69330372D1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
ES479102A1 (es) Procedimiento para preparar una composicion catalitica a ba-se de titanio y magnesio.
Courouce et al. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays)
DK130686B (da) Fremgangsmåde til udvinding af polyisopren eller lignende gummiagtige polymere fra organiske opløsninger.
ATE303597T1 (de) Hcv mosaik antigen zusammensetzung
ES2286212T3 (es) Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
ES2146574T3 (es) Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.
DK144543C (da) Diagnostisk fremgangsmaade in vitro,ved hvilken lymfocyter inkuberes med antigener
ES479101A1 (es) Procedimiento para preparar una composicion catalitica a ba-se de titanio y magnesio.
NL169068B (nl) Werkwijze ter bereiding van methacrylzuur door oxydatie van methacroleien en werkwijze ter bereiding van een hierbij bruikbare katalysator, alsmede voorwerpen vervaardigd uit deze katalysator.
ES2070127T3 (es) Procedimiento para preparar n-acil-anilinas.
DE69009050D1 (de) Verfahren zur stabilisierung der hybridisierung von komplementären polynukleotidsequenzen.
LEE et al. Usefulness of HCV core protein for detection of HCV viremia
KR790000147B1 (en) Method of preparation for 2,6-diamino-dihydropyrimidwes
UA33753A (uk) Спосіб отримання 2-ариліден-п-ментан-3-онів
JPS5359687A (en) Recovering method of epsilon-caprolactam

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time